Literature DB >> 27300556

MELD-XI Scores Correlate with Post-Fontan Hepatic Biopsy Fibrosis Scores.

William N Evans1,2, Ruben J Acherman3,4, Michael L Ciccolo3,4, Sergio A Carrillo3,4, Alvaro Galindo3,4, Abraham Rothman3,4, Brody J Winn5, Noel S Yumiaco5, Humberto Restrepo3,4.   

Abstract

We tested the hypothesis that MELD-XI values correlated with hepatic total fibrosis scores obtained in 70 predominately stable, post-Fontan patients that underwent elective cardiac catheterization. We found a statistically significant correlation between MELD-XI values and total fibrosis scores (p = 0.003). Thus, serial MELD-XI values may be an additional useful clinical parameter for follow-up care in post-Fontan patients.

Entities:  

Keywords:  Fontan; Hepatic fibrosis; Liver biopsy; MELD-XI

Mesh：

Year:  2016        PMID： 27300556     DOI： 10.1007/s00246-016-1428-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  10 in total

1.  MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.

Authors:  Douglas M Heuman; Anastasios A Mihas; Adil Habib; Hochong S Gilles; R Todd Stravitz; Arun J Sanyal; Robert A Fisher
Journal:  Liver Transpl       Date:  2007-01       Impact factor: 5.799

Review 2.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

3.  Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery.

Authors:  Matthew C Schwartz; Lisa M Sullivan; Andrew C Glatz; Elizabeth Rand; Pierre Russo; David J Goldberg; Jonathan J Rome; Meryl S Cohen
Journal:  Pediatr Cardiol       Date:  2012-06-14       Impact factor: 1.655

4.  Transvenous hepatic biopsy in stable Fontan patients undergoing cardiac catheterization.

Authors:  William N Evans; Brody J Winn; Noel S Yumiaco; Alvaro Galindo; Abraham Rothman; Ruben J Acherman; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2014-05-10       Impact factor: 1.655

5.  Fontan Liver Disease: Review of an Emerging Epidemic and Management Options.

Authors:  Elisa Bradley; Benjamin Hendrickson; Curt Daniels
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

6.  MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.

Authors:  Gabriele Egidy Assenza; Dionne A Graham; Michael J Landzberg; Anne Marie Valente; Michael N Singh; Aamir Bashir; Susan Fernandes; Koenraad J Mortele; Chinweike Ukomadu; Massimo Volpe; Fred Wu
Journal:  Heart       Date:  2013-02-13       Impact factor: 5.994

7.  Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy?

Authors:  Gabriella Agnoletti; Gaetana Ferraro; Roberto Bordese; Davide Marini; Simona Gala; Laura Bergamasco; Francesca Ferroni; Pier Luigi Calvo; Claudio Barletti; Fabio Cisarò; Filomena Longo; Carlo Pace Napoleone
Journal:  Int J Cardiol       Date:  2016-02-03       Impact factor: 4.164

8.  Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.

Authors:  Margaret S Kim; Tomoko S Kato; Maryjane Farr; Christina Wu; Raymond C Givens; Ellias Collado; Donna M Mancini; P Christian Schulze
Journal:  J Am Coll Cardiol       Date:  2013-04-03       Impact factor: 24.094

Review 9.  The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium.

Authors:  Jack Rychik; Gruschen Veldtman; Elizabeth Rand; Pierre Russo; Jonathan J Rome; Karen Krok; David J Goldberg; Anne Marie Cahill; Rebecca G Wells
Journal:  Pediatr Cardiol       Date:  2012-04-26       Impact factor: 1.655

10.  Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.

Authors:  Satoshi Abe; Akiomi Yoshihisa; Mai Takiguchi; Takeshi Shimizu; Yuichi Nakamura; Hiroyuki Yamauchi; Shoji Iwaya; Takashi Owada; Makiko Miyata; Takamasa Sato; Satoshi Suzuki; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Koichi Sugimoto; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240
  10 in total
  10 in total

1.  Liver Strain Using Feature Tracking of Cine Cardiac Magnetic Resonance Imaging: Assessment of Liver Dysfunction in Patients with Fontan Circulation and Tetralogy of Fallot.

Authors:  Ryoko Ohashi; Michinobu Nagao; Umiko Ishizaki; Yumi Shiina; Kei Inai; Shuji Sakai
Journal:  Pediatr Cardiol       Date:  2019-12-18       Impact factor: 1.655

2.  Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion.

Authors:  Gaku Izumi; Atsuhito Takeda; Hirokuni Yamazawa; Osamu Sasaki; Nobuyasu Kato; Hidetsugu Asai; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

Review 3.  Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients With Congestive Hepatopathy.

Authors:  Alexander Lemmer; Lisa B VanWagner; Daniel Ganger
Journal:  Hepatology       Date:  2018-09-22       Impact factor: 17.425

Review 4.  Screening modalities for the diagnosis of Fontan-associated liver disease: evidence from the past for future development.

Authors:  Saviga Sethasathien; Krit Leemasawat; Suchaya Silvilairat; Rekwan Sittiwangkul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

5.  Risk factors for Fontan-associated hepatocellular carcinoma.

Authors:  Tomomi Kogiso; Takaomi Sagawa; Makiko Taniai; Eriko Shimada; Kei Inai; Tokuko Shinohara; Katsutoshi Tokushige
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

6.  Biomarker profile in stable Fontan patients.

Authors:  Anita Saraf; Christine De Staercke; Ian Everitt; Alice Haouzi; Yi-An Ko; Staci Jennings; Jonathan H Kim; Fred H Rodriguez; Andreas P Kalogeropoulos; Arshed Quyyumi; Wendy Book
Journal:  Int J Cardiol       Date:  2020-01-09       Impact factor: 4.164

7.  Fontan-associated liver disease and hepatocellular carcinoma in adults.

Authors:  Tomomi Kogiso; Katsutoshi Tokushige
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

Review 8.  Congestive Hepatopathy.

Authors:  José Ignacio Fortea; Ángela Puente; Antonio Cuadrado; Patricia Huelin; Raúl Pellón; Francisco José González Sánchez; Marta Mayorga; María Luisa Cagigal; Inés García Carrera; Marina Cobreros; Javier Crespo; Emilio Fábrega
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

9.  Potential of Liver T1 Mapping for the Detection of Fontan-associated Liver Disease in Adults.

Authors:  Yumi Shiina; Kei Inai; Ryoko Ohashi; Michinobu Nagao
Journal:  Magn Reson Med Sci       Date:  2020-09-07       Impact factor: 2.471

10.  Non-invasive biomarkers of Fontan-associated liver disease.

Authors:  Juliet Emamaullee; Sara Khan; Carly Weaver; Cameron Goldbeck; George Yanni; Rohit Kohli; Yuri Genyk; Shengmei Zhou; Nick Shillingford; Patrick M Sullivan; Cheryl Takao; Jon Detterich; Paul F Kantor; John D Cleveland; Cynthia Herrington; S Ram Kumar; Vaughn Starnes; Sarah Badran; Neil D Patel
Journal:  JHEP Rep       Date:  2021-09-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.